Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrocaps in Liver Resection Hemostasis
NCT01256190Phase 2Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Dec 2010
- Primary completion
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of fibrinogen + thrombin in postoperative hemorrhage (2 arms), sponsored by Mallinckrodt Pharmaceuticals. Primary endpoint: Time to Hemostasis. Started Dec 2010; status: completed.
02
Drugs
fibrinogen + thrombin
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT01256190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01256190.